Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
17.12.25
/
50%
€5.85
Target price
17.12.26
-
Performance (%)
0.00%
Price
16:12
€5.85
Summary
This prediction is currently active. Cantor_Fitzgerald's BUY prediction for Vanda Pharmaceuticals is currently unchanged. This prediction currently runs until 17.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vanda Pharmaceuticals | 0.00% |
| iShares Core DAX® | -1.212% |
| iShares Nasdaq 100 | -4.714% |
| iShares Nikkei 225® | -2.976% |
| iShares S&P 500 | -2.744% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (NASDAQ:VNDA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
64.33%
16:12
16:12
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25